Dr. Brian Weiss, MD
Claim this profileCincinnati Children's Hospital Medical Center
Area of expertise
Neuroblastoma
Brian Weiss, MD has run 17 trials for Neuroblastoma. Some of their research focus areas include:
Cancer
Brian Weiss, MD has run 8 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Cincinnati Children's Hospital Medical Center
Riley Hospital For Children
Clinical Trials Brian Weiss, MD is currently running
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting
1 award
Phase 1 & 2
13 criteria
Lorlatinib + Standard Therapy
for Neuroblastoma
This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, such as iobenguane I-131, may carry radiation directly to tumor cells and not harm normal cells. Lorlatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving iobenguane I-131 or lorlatinib and standard therapy may work better compared to lorlatinib and standard therapy alone in treating younger patients with neuroblastoma or ganglioneuroblastoma.
Recruiting
2 awards
Phase 3
22 criteria
More about Brian Weiss, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 27 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Brian Weiss, MD has experience with
- Dinutuximab
- Vorinostat
- 131I-MIBG
- Temozolomide
- Lorlatinib
- Cyclophosphamide
Breakdown of trials Brian Weiss, MD has run
Neuroblastoma
Cancer
Neurofibromatosis
Ganglioneuroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian Weiss, MD specialize in?
Brian Weiss, MD focuses on Neuroblastoma and Cancer. In particular, much of their work with Neuroblastoma has involved MYC positive patients, or patients who are Stage IV.
Is Brian Weiss, MD currently recruiting for clinical trials?
Yes, Brian Weiss, MD is currently recruiting for 5 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Brian Weiss, MD has studied deeply?
Yes, Brian Weiss, MD has studied treatments such as Dinutuximab, Vorinostat, 131I-MIBG.
What is the best way to schedule an appointment with Brian Weiss, MD?
Apply for one of the trials that Brian Weiss, MD is conducting.
What is the office address of Brian Weiss, MD?
The office of Brian Weiss, MD is located at: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039 United States. This is the address for their practice at the Cincinnati Children's Hospital Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.